An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder

Lignende værker

• An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
  af: Pandina Gahan, et al.
  Udgivet: (2012-06-01)
• An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
  af: Pandina, Gahan, et al.
  Udgivet: (2012)
• Cognitive functioning in adolescents with schizophrenia treated with paliperidone extended-release: 6-Month exploratory analysis from an open-label, single-arm safety study()
  af: Pandina, Gahan, et al.
  Udgivet: (2020)
• An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder
  af: Desousa, Avinash
  Udgivet: (2010)
• Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases
  af: Alphs, Larry, et al.
  Udgivet: (2011)